1 June 2011
14:00-18:15
Room Lehar
This is a public workshop which will highlight the main results of the NAD project (Title: Nanoparticles for Therapy and Diagnosis of Alzheimer Disease - one of the most successful projects at the EU FP7 Health/NANO area) achieved during the very intensive research collaboration of 19 partners of an international consortium on the field of Alzheimer / nanomedicine research.
Preliminary agenda
14.00 Opening – Project overview
Prof. Massimo Masserini, scientific coordinator of the NAD “Nanoparticles for Therapy and Diagnosis of Alzheimer Disease” project, Universita Degli Studi Di Milano – Bicocca, Milano, Italy
Presentation from Invited Speakers
14.20 “Nanomedicines: opportunities and challenges“
Dr. Theresa M. Allen, Division Chair. Drug Delivery, Center for Drug Research and Development (CDRD), Univerity of Alberta, USA
14.55 “Dendrimer Nanocomposites in Imaging and Therapy”
Prof. Lajos Balogh, Editor-in-Chief of the journal Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier), CEO of AA NANOMED Consulting, a former Professor of the Roswell Park Cancer Institute, of the University at Buffalo, SUNY, and of the University of Michigan, Ann Arbor, MI.
Presentation of young researchers of the NAD project consortium
15.30 “New Abeta peptide ligands for the diagnosis and therapy of Alzheimer’s Disease”
Erica Sironi, Universita Degli Studi Di Milano – Bicocca, Milano, Italy
15.45 “Interaction of monomeric amyloid beta-protein (A?-42) with anionic phospholipids: Experimental experiments”
Hasna Ahyayauch, Univerity of the Basque County, Bilbao, Spain
16.00 BREAK
16.30 “Interaction of monomeric amyloid beta-protein (A?-42) with anionic phospholipids: Simulation experiments”
Michael Raab, Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia
16.45 “Optimization of the click reaction on nanoliposome surface for preparation of various types of vesicles decorated with a curcumin-derivative”
Spyros Mourtas, University of Patras, Patras, Greece
17.00 “Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer’s A? peptide”
Mark Taylor, Lancaster University, Lancaster, United Kingdom
17.15 “Functionalized PEGylated Poly(AlkylCyanoacrylate)Nanoparticles for Applications in Alzheimer’s Disease”
Benjamin Le Droumaguet, Université Paris-Sud XI, Orsay, France
17.30 “ApoE-nanoliposomes for transport of Ab1-42-ligands across the blood-brain barrier: a study in a model system”
Francesca Re, Universita Degli Studi Di Milano – Bicocca, Milano, Italy
17.45 “In vivo PET imaging of amyloid plaques in experimental animals”
Anniina Pakkanen, Turun Yliopisto, Turku, Finland
18.00 Discussion, closing remarks
Prof. Massimo Masserini, Universita Degli Studi Di Milano – Bicocca, Milano, Italy
18.15 END
